AI Prime is a life sciences company focused on developing oncology therapeutics targeting the growth and proliferation of cancer cells.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 6, 2022 | Series A | — | 1 | Suzhou Zhongxin Innovation Investment Management | — | Detail |
Jul 1, 2020 | Seed | — | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Suzhou Zhongxin Innovation Investment Management | Yes | Series A |
Zhidao Capital | — | Seed |
Shenzhenshi Dexun Touzi | — | Seed |